vcp protein expression Search Results


90
Koganei Corporation recombinant e. rhusiopathiae bacteria expressing the c-terminal portion of the p97 protein of m. hyponeumoniae
Details of the vaccination/immunization regimen showing induction of the common mucosal immune responses from the highlighted literature.
Recombinant E. Rhusiopathiae Bacteria Expressing The C Terminal Portion Of The P97 Protein Of M. Hyponeumoniae, supplied by Koganei Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vcp+protein+expression/recombinant+e++rhusiopathiae+bacteria+expressing+the+c+terminal+portion+of+the+p97+protein+of+m++hyponeumoniae/pmc07132386-198-38-2
Average 90 stars, based on 1 article reviews
recombinant e. rhusiopathiae bacteria expressing the c-terminal portion of the p97 protein of m. hyponeumoniae - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Details of the vaccination/immunization regimen showing induction of the common mucosal immune responses from the highlighted literature.

Journal: Molecular Immunology

Article Title: Evidence for a common mucosal immune system in the pig ☆

doi: 10.1016/j.molimm.2014.09.004

Figure Lengend Snippet: Details of the vaccination/immunization regimen showing induction of the common mucosal immune responses from the highlighted literature.

Article Snippet: E. rhusiopathiae Koganei (65–0.15 strain) is a bacteria that colonizes the tonsils of pigs and which can be used to protect pigs against erysipelas. created recombinant E. rhusiopathiae bacteria expressing the C-terminal portion of the P97 protein of M. hyponeumoniae ( ) for use as a vaccine.

Techniques: Derivative Assay, Adjuvant, Virus, Irradiation, Aerosol, Clinical Proteomics, Bacteria, Control, Construct, Plasmid Preparation, Expressing, Infection